SHARON WINTER-SCAVICCHIO: Open Payments
NPI 1255518411 · SEWELL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,216 in 58 payments from 18 companies in 2025. Trend: 2023 $2,181 · 2024 $2,742 · 2025 $1,216
Food & beverage: $1,216
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $339 |
| Axsome Therapeutics, Inc. | 10 | $155 |
| PFIZER INC. | 6 | $118 |
| ABBVIE INC. | 5 | $110 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Exact Sciences Corporation | 2 | $50 |
| Astellas Pharma US Inc | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
Products named: Ozempic, Auvelity, Wegovy, TRELEGY ELLIPTA, UBRELVY, Veozah, PAXLOVID, XIFAXAN.
Industry payments across NJ — which companies pay providers there.
